CS

Pavel Majer

mail pavel.majerinvalid-email-name@invalid-email-domainuochb.cas.cz
phone +420 220 183 125
Group leader
Drug Discovery
Pavel Majer Group
All publications

Latest publications

Chemical Blockage of the Mitochondrial Rhomboid Protease PARL by Novel Ketoamide Inhibitors Reveals Its Role in PINK1/Parkin-Dependent Mitophagy
E. Poláchová K. Bach E. Heuten S. Stanchev A. Tichá P. Lampe P. Majer T. Langer M. K. Lemberg K. Stříšovský
Journal of Medicinal Chemistry 66 (1): 251–265 (2023)
Go to the publication arrow
Identification of specific carbonic anhydrase inhibitors via in situ click chemistry, phage-display and synthetic peptide libraries: comparison of the methods and structural study
M. Kugler M. Hadzima R. Dzijak R. Rampmaier P. Srb L. Vrzal Z. Voburka P. Majer P. Řezáčová M. Vrábel
RSC Medicinal Chemistry 1 (14): 144-153 (2023)
Go to the publication arrow
Unique peptidic agonists of a juvenile hormone receptor with species-specific effects on insect development and reproduction
Š. Tůmová M. Miláček I. Šnajdr M. Muthu R. Tůma D. Řeha P. Jedlička L. Bittová A. Novotná P. Majer D. Sedlák M. Jindra
Proceedings of the National Academy of Sciences of the United States of America 119 (48): e2215541119 (2022)
Go to the publication arrow